ProfileGDS4459 / ENSG00000186967
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 18% 31% 16% 14% 14% 15% 10% 10% 12% 15% 13% 11% 13% 36% 11% 35% 13% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.2818
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.8231
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 32.716
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.214
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 52.7314
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 62.9615
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 72.3710
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 82.3210
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 92.4412
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 102.7515
GSM623474group B, liver allograft wedge biopsie placebo treatment 12.8213
GSM623475group B, liver allograft wedge biopsie placebo treatment 22.3111
GSM623476group B, liver allograft wedge biopsie placebo treatment 32.6513
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.9736
GSM623478group B, liver allograft wedge biopsie placebo treatment 52.3611
GSM623479group B, liver allograft wedge biopsie placebo treatment 63.9335
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.0613